Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation

Emilie Seydoux(Fred Hutch Cancer Center), Leah J. Homad(Fred Hutch Cancer Center), Anna J. MacCamy(Fred Hutch Cancer Center), K. Rachael Parks(Infectious Disease Research Institute), Nicholas K. Hurlburt(Fred Hutch Cancer Center), Madeleine F. Jennewein(Fred Hutch Cancer Center), Nicholas R. Akins(Fred Hutch Cancer Center), Andrew B. Stuart(Fred Hutch Cancer Center), Yu-Hsin Wan(Fred Hutch Cancer Center), Junli Feng(Fred Hutch Cancer Center), Rachael E. Whaley(Fred Hutch Cancer Center), Suruchi Singh(Fred Hutch Cancer Center), Michael Boeckh(University of Washington), Kristen W. Cohen(Fred Hutch Cancer Center), M. Juliana McElrath(Infectious Disease Research Institute), Janet A. Englund(Seattle Children's Hospital), Helen Y. Chu(University of Washington), Marie Pancera(Fred Hutch Cancer Center), Andrew T. McGuire(Infectious Disease Research Institute), Leonidas Stamatatos(University of Washington)
Immunity
June 8, 2020
10.1016/j.immuni.2020.06.001
Cited by 441Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis